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Background: Aromatic amino acid decarboxylase (AADC) deficiency is a rare
autosomal recessive disorder resulting in a combined dopamine and serotonin
deficiency. About 50% of the cases set in the neonatal period. Here, we report an
atypical clinical presentation with moderate symptoms. Patient: At 10months old, the
patient presented paroxysmal eye movements without seizures, and feeding
difficulties which were attributed to gastroesophageal reflux. She was investigated at
the age of 7years, because of orofacial dyspraxia, hypomimie, axial hypotonia and
focal segmental dystonia, bilateral ptosis, without evidence for cognitive impairment.
Results: HVA [110nM; (reference value (rv): 202–596)] and HIAA (12nM; rv: 87–366)
decreased, OMD (520nM; rv: 5–60) and 5-HTP (56nM; rv: 2–16) increased in CSF.
We confirmed the diagnosis of AADC deficiency because the activity in plasma was
low: 4pmol/min/ml; rv: 16–137. The kinetic analysis revealed a sixfold increase in the
apparent affinity for l-dopa (4.26mM; control=0.71), but the V max was unchanged
(37.5pmol dopamine/min/ml; control=39.1), suggesting a modification in the
substrate binding-site. Molecular analysis revealed two heterozygous mutations in
the DDC gene: c1040G > A; pR347Q already described, and a novel mutation c478C
> T, pR160W. Conclusion: (1) CSF neurotransmitters metabolites suggested a
moderate AADC deficiency; (2) The initial velocity saturation curve for l-dopa
displayed a cooperative ligand binding behavior, in keeping with the modifications of
the three-dimensional structure, induced by the amino acid substitutions (3) The
treatment combination of l-dopa with pyridoxine dramatically improved the quality of
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